publication date: Jul. 22, 2011

This issue is free and open to the public.

  • A Year at NCI: Harold Varmus Reflects on Provocative Questions, the Duke Scandal, Financial Disaster and Grant Review
  • Part one of a two-part interview with NCI Director Harold Varmus
  • Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication
  • ODAC Votes for Accelerated Approval for Adcetris for Two Lymphoma Indications
  • Richard Pazdur’s Comments to ODAC
  • Department of Defense offering $16 million in Cancer Research Grants

Copyright (c) 2020 The Cancer Letter Inc.